Use of propofol and other nonbenzodiazepine sedatives in the intensive care unit

Critical Care Clinics

Volumn 17, Issue 4, 2001, Pages 863-880

  Angelini, Giuditta ^a   Ketzler, Jonathan T ^a   Coursin, Douglas B ^a  

^a University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANXIOLYTIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROMOCRIPTINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DANTROLENE; DEXMEDETOMIDINE; DIGOXIN; ETOMIDATE; GLYCOPYRRONIUM BROMIDE; HALOPERIDOL; IMIDAZOLE DERIVATIVE; KETAMINE; LORAZEPAM; METHOHEXITAL; MIDAZOLAM; NARCOTIC AGENT; OSMOTIC DIURETIC AGENT; PENTOBARBITAL; PHENCYCLIDINE DERIVATIVE; PHENYTOIN; PROPOFOL; SEDATIVE AGENT; SEVOFLURANE; THIOBARBITURIC ACID DERIVATIVE; THIOPENTAL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

AGITATION; AMNESIA; CLINICAL TRIAL; CONFUSION; CRITICAL ILLNESS; DELIRIUM; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG MECHANISM; HEMODYNAMICS; HUMAN; INTENSIVE CARE; PAIN; PRIORITY JOURNAL; REVIEW; SEDATION; SIDE EFFECT;

EID: 0035190919     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0704(05)70184-6     Document Type: Article

References (64)

1. Randomized clinical study of thiopental loading on comatose survivors of cardiac arrest: Brain resuscitation clinical trial (BRCT) I study group
2. Pharmacokinetics of long-term propofol infusion used for sedation in ICU patients
3. An evidence-based approach to management of increased intracranial pressure
4. Prolonged sedation of critically ill patients with midazolam or propofol: Impact on weaning and costs
5. Sedation in the intensive care - A postal survey
6. Effects of intravenous dexmedetomidine in humans
7. Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients
8. Synergistic sedation with propofol and midazolam in intensive care patients after coronary bypass grafting
9. Comparative study of propofol versus midazolam in the sedation of critically ill patients: Results of a prospective, randomized, multicenter trial
10. Pharmacokinetics of thiopentone in a group of young women and a group of young men
11. Alterations in metabolism following injury: Part I
12. Ketamine anethesia for tangential excision of burn eschar: A bum unit procedure
13. Motor activity assessment scale: A valid and reliable sedation scale for use with mechanically ventilated patients in an adult surgical intensive care unit
14. Comparison of the effects of etomidate, propofol, and thiopental on respiratory resistance following tracheal intubation
15. The effect of thiopental on peripheral venous tone
16. Safer sedation for ventilated patients: A new application for etomidate
17. Use of etomidate in an intensive care unit
18. Ketoconazole and other imidazole derivatives as inhibitors of steroidogenesis
19. Propofol: An overview of its pharmacology and a review of its clinical efficacy in intensive care sedation
20. Lethal catatonia complicated by the development of the neuroleptic malignant syndrome in a middle aged female
21. Sympathoadrenal hyperactivity and the etiology of neuroleptic malignant syndrome
22. Assessment of sedation, analgesia, and neuromuscular blockade in the perioperative period
23. Concerns about sedation and paralysis in the ICU
24. Beyond the Ramsay scale: Need for a validated measure of sedating drug efficacy in the intensive care unit
25. A consideration of ketamine dreams
26. Effect of propofol on elevated intracranial pressure. Preliminary results
27. The association between intravenous haloperidol and torsades de pointes
28. Revised clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult
29. Status epilepticus. A perspective from the neuroscience intensive care unit
30. Propofol in the treatment of moderate to severe head trauma: A randomized, prospective, double-blinded pilot trial
31. Alpha-2 and imidazoline receptor agonists
32. Ketamine: Teaching an old drug new tricks
33. Sedation of critically ill patients during mechanical ventilation. A comparison of propofol and midazolam
34. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation
35. Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill: A review of the literature
36. Propofol infusion for control of status epilepticus
37. Continuous infusions of lorazepam, midazolam, and propofol for sedation of the critically ill surgery trauma patient: A prospective, randomized comparison
38. Refractory delirium tremens treated with propofol: A case series
39. Propofol 2% in critically ill patients: Effect on lipids
40. Induction characteristics of propofol in children: Comparison with thiopentone
41. Propofol or thiopentone: Effects on intraocular pressure associated with induction of anaesthesia and tracheal intubation (facilitated with suxamethonium)
42. Bacterial contamination of an anesthetic agent
43. Barbiturates
44. Prevention of pain on injection with propofol: A quantitative systematic review
45. Cardiovascular and ventilatory effects of intravenous anesthetics
46. Complications associated with sedative and neuromuscular blocking drugs in critically ill patients
47. Controlled sedation with alphaxalone-alphadolone
48. An electroencephalographic comparison of effects of propofol and methohexital
49. Continuous infusion of haloperidol controls agitation in critically ill patients
50. Prospective evaluation of the sedation-agitation scale for adult critically ill patients
51. Assessing sedation levels in mechanically ventilated ICU patients with the bispectral index and the sedation-agitation scale
52. Continuous infusion of haloperidol controls agitation in critically ill patients
53. Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens
54. Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: An executive summary
55. Synergistic sedation: Some credible data and a word of caution
56. Barbiturates in brain ischaemia
57. Effects of Disoprivan on cerebral blood flow, oxygen consumption and cerebral vascular reactivity
58. Thiopental attenuates energetic impairment but fails to normalize cerebrospinal fluid glutamate in brain-injured patients
59. Pharmacokinetics of etomidate: A new intravenous anesthetic
60. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit
61. Drugs for amnesia in the ICU
62. Contamination of propofol infusions in the intensive care unit: Incidence and clinical significance
63. Ketamine-Its pharmacology and therapeutic uses
64. Sedation in the intensive care unit